Navigation Links
Major State Grant Accelerates Research and Development of Novel Cancer Therapy
Date:9/5/2008

BOCA RATON, Fla., Sept. 5 /PRNewswire-USNewswire/ -- The Florida Technology, Research and Scholarship Board recently awarded Florida Atlantic University researcher Dr. Herbert Weissbach, distinguished professor and director of the Center for Molecular Biology and Biotechnology in the Charles E. Schmidt College of Science, and CHS Resources LLC (CHS), $184,294 as part of the State University Research Commercialization Assistance Grant program (SURECAG). SURECAG was established by the Florida Legislature in 2007 to promote the commercialization of university research products to enhance the state's economy and its public universities. With these funds, universities are able to promote their commercialization endeavors by securing patents, establishing startup companies, developing licensing agreements and attracting private investments.

FAU, together with CHS (which licensed this technology from FAU), submitted a proposal for Weissbach's discovery of a novel combination of agents that work to preferentially target and kill cancer cells. In addition, CHS was instrumental in providing FAU with a matching grant -- a stipulation of the SURECAG program -- for a total of $368,588 for research and development. CHS is currently developing this therapy for treatment of actinic keratosis (AK), a precancerous skin condition, and "proof-of-concept" studies are ongoing. CHS is simultaneously developing an over-the-counter skin protective agent with unique antioxidant properties.

"SURECAG is designed to create a more vital link between venture capitalists, industry and Florida's state universities," said Dr. Gary Perry, dean of the Charles E. Schmidt College of Science. "This grant is essential to support product development activities necessary to help CHS obtain approval from the FDA to perform clinical trials that will lead to drug approval."

Weissbach and his team initially identified a lead compound that in combination with an oxidizing agent or age
'/>"/>

SOURCE Florida Atlantic University
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
5. ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
6. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
7. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
10. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
11. Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCall/...s Division is pleased to announce the signing of a...tates Department of Defense that may lead to the c...revolutionize the treatment of the limbs of soldie...ar, the Defense Advanced Research Projects Agency ...
(Date:11/19/2009)..., BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCa...RX ) today announced the pricing of a public offer...75 per share, resulting in gross proceeds of $48.7... BioCryst pursuant to an effective shelf registrat... and Exchange Commission. BioCryst has also grant...
(Date:11/19/2009)..., TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/...e pharmaceutical ingredients (APIs), announced tha...ound Safety Certification from,SafeBridge(R) Consu...,s,competency and proficiency in the safe handling...), and applies to specific laboratories and,produc...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Study shows how normal cells influence tumor growth 59935 1Study shows how normal cells influence tumor growth 59935 2Bolton School of Nursing at CWRU receives 243 7 million in federal stimulus funding 59933 1Bolton School of Nursing at CWRU receives 243 7 million in federal stimulus funding 59933 2Sex With a Partner Makes Evolutionary Sense 3A Study 59931 1Sex With a Partner Makes Evolutionary Sense 3A Study 59931 2
...ne in the Treatment of Patients with Relapsed/Ref...ented Tomorrow, Tuesday, June 3rd at 12:0...rmaceuticals,Inc. (Nasdaq: KERX ) today announced...ave been selected for both poster presentation and...al Oncology Meeting,currently taking place in Chic...
...erican Society of Clinical Oncology (ASCO),annual ...vival vs. external c...c.,(Nasdaq: IDMI ) today announced follow-up resu...t the product candidate was well tolerated, induce...sponses, and showed a,positive survival trend in H...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 4Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 5IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 2IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 3IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 4
(Date:11/20/2009)..., CHICAGO, Nov. 20 Th...e U.S. Food and Drug Administration (FDA) to estab...ng chemicals. ,, Citing concern about the safe...ed without the benefit of professional consultatio...d that the application of chemically based tooth w...
(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNew... on a mission to redefine what it means to be "hap...l counselor with a specialty in family counseling ...Forest University, Gladding says research shows th... to sadness and even depression during the holiday...
(Date:11/20/2009)...itorial published online November 20 in the Journ... exaggerated fears and hopes that often appear in ...ovides guidance for both the media and journals to... M.D., M.S., and Steven Woloshin, M.D., M.S., of C...Institute for Health Policy and Clinical Practice ...
(Date:11/20/2009)...tle, Washington) November 20, 2009Emergency medica...ess an estimated 350,000 cardiac arrests each year...cardiac arrest survive. Better quality cardiopulm...EMS providers may be associated with better patien...(ROC) is the largest clinical research network to ...
(Date:11/20/2009)...rs save up to one-third buying 90-day supply, stud...ews) -- Buying a three-month supply of prescriptio...ne-month supply, according to a new study. , U....d for 395 drugs between 2000 and 2005, and found t...ad of a one-month supply saved an average 29 perce...
Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2
...new genetic discovery could help give insight into...variations in the gene // that codes for the proge...n cancer. The PGR had previously been linked to...nd examined the variety of gene variations found i...
...ss sleep could make you fat. In an editorial publi...nal Medicine, two Northwestern University research...wing epidemic of obesity in the United States by s...ty studies also published this week in the journal...
...new discovery reveals a new cause of thyroid cance...oid tumors, one of three genetic changes // happe...en patients have not been exposed to radiation, th..., the gene changes or mutations transform normal c...
...new study shows a clear link between fast food con...uggesting that // fast food increases the risk of ...igated the association between reported fast food ...at changes in fast food frequency over 15 years wa...
...new study shows choosing to have implants after a ...of the patient. Researchers say they found that wo...than those who did not have implants.// Resear... that breast implants could stimulate the immune s...
...graine headaches, usually an inherited disorder, a... adolescence, // according to researchers. The pai...nd effective for treating migraine headaches in ch...uated over 166 articles and abstracts on children ...
Other Medicine News:Health News:Sleeping Less May be related to Weight Gain 2
...atesthat is the area of research in which the mult...rce. Ergonomics (reduced weight and ease of use) w...model was developed. This high-performance 8- or 1... rapid processing of long series for a wide spectr...
Finnpipette Digital Multichannel, 12 Channel 5-50ul
...ue!, Comfortable feel and less hand fatigue with ...ile pipetting with smooth, light plunger spring ac...ip ejector , Completely autoclavable for easy deco... recalibration , Easy-to-read precision micrometer...
...atesthat is the area of research in which the mult...rce. Ergonomics (reduced weight and ease of use) w...model was developed. This high-performance 8- or 1... rapid processing of long series for a wide spectr...
Medicine Products: